Document Detail

Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma.
MedLine Citation:
PMID:  25474516     Owner:  NLM     Status:  Publisher    
Previous studies have reached conflicting results regarding whether tumour necrosis is a predictor of survival in clear cell renal cell carcinoma. In addition, studies quantifying the extent of necrosis are limited.The aim of this study was to determine if quantifying tumour necrosis could improve its predictive value for survival in clear cell renal cell carcinoma.We reviewed the clinical pathological information contained in The Cancer Genome Atlas for clear cell renal cell carcinoma and correlated it with overall survival using a Cox proportional hazard model. Necrosis was quantified on a single frozen section slide taken at the time of tissue harvesting for molecular studies.For all tumours, the presence of tumour necrosis was a significant predictor of overall survival (p < 0.001) on univariate analysis. When quantitated, >10% necrosis was associated with survival, but ≤10% necrosis was not. On multivariate analysis, age (p = 0.004), T3b stage (p = 0.02), M1 stage (p < 0.001), necrosis >30% (p < 0.001), and elevated serum calcium (p = 0.003) remained significant. For clinical stage 1-2 (T1-T2N0M0) tumours, necrosis >20% was significant on univariate analysis (p ≤ 0.005), and remained so on multivariate analysis (p < 0.001).We conclude that quantitating the extent of tumour necrosis adds prognostic information in clear cell renal cell carcinomas, including organ confined tumours.
Andrew A Renshaw; John C Cheville
Related Documents :
22654996 - Algorithms for optimization of the transport system in living and artificial cells.
22672996 - Abl1 joins the cadre of spindle orientation machinery.
25296906 - Upregulated expression of monocyte chemoattractant protein-1 in human periodontal ligam...
25391656 - Mir-200 is induced by thioredoxin-interacting protein and regulates zeb1 signaling and ...
11896576 - Sp1 as g1 cell cycle phase specific transcription factor in epithelial cells.
23533596 - Overexpression of cd151 predicts prognosis in patients with resected gastric cancer.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-12-3
Journal Detail:
Title:  Pathology     Volume:  -     ISSN:  1465-3931     ISO Abbreviation:  Pathology     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-4     Completed Date:  -     Revised Date:  2014-12-5    
Medline Journal Info:
Nlm Unique ID:  0175411     Medline TA:  Pathology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cel...
Next Document:  Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus.